Background Current therapies for recurrent Clostridioides difficile infection do not address
the disrupted microbiome, which supports C. difficile spore germination into toxin-producing …

Objectives: To determine mortality rates among adults with critical illness from coronavirus
disease 2019. Design: Observational cohort study of patients admitted from March 6, 2020, to …

Ebola virus disease (EVD) is a severe and frequently lethal disease caused by Ebola virus (EBOV).
EVD outbreaks typically start from a single case of probable zoonotic transmission, …

Background. The current West Africa Ebola virus disease (EVD) outbreak has resulted in
multiple individuals being medically evacuated to other countries for clinical management. …

Multidrug-resistant organism (MDRO) colonization is a fundamental challenge in antimicrobial
resistance. Limited studies have shown that fecal microbiota transplantation (FMT) can …

<p id="p001">Among the survivors of Ebola virus disease (EVD), complications that include
uveitis can develop during convalescence, although the incidence and pathogenesis of EVD…

<p id="p002">West Africa is currently experiencing the largest outbreak of Ebola virus disease
(EVD) in history. Two patients with EVD were transferred from Liberia to our hospital in the …

Background. Patients with recurrent Clostridium difficile infection (CDI) have a ≥60% risk of
relapse, as conventional therapies do not address the underlying gastrointestinal dysbiosis. …

Four Ebola patients received care at Emory University Hospital, presenting a unique opportunity
to examine the cellular immune responses during acute Ebola virus infection. We found …

Background Baricitinib and dexamethasone have randomised trials supporting their use for
the treatment of patients with COVID-19. We assessed the combination of baricitinib plus …